Telesis Bio Inc.
DNA synthesis hardware and synthetic DNA oligonucleotides, including the BioXp DNA printer
- Sector
- Biotech
- Headquarters
- SAN DIEGO, CA
- Latest Form D
- $28M, Jun 2023
- Total capital
- $28.3M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $28M
- 1 Form D · last Jun 2023
- 40 months since last filing
- Federal contracts
- $337K
- 9 awards · Defense, Commerce, Health and Human S
- Rank in Biotech#253 of 4373
- Granted patents
- 1
- 10 pending · first 2026
- Rank in peer group#11 of 32
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$28M
- Federal contractHealth and Human S · For COVID-19 Bioxp 3250 System Includes Training, Installation And Case Of Tips$100K
- Federal contractAgriculture · Synthetic Dna$25K
- Federal contractAgriculture · Bioxp 3200 System As Per Quote QUO-01450-L8R8Y5$77K
- Federal contractDefense · Bio XP3200 System$58K
- Federal contractHealth and Human S · Igf::ot::igf Service Agreement$5K
- Federal contractHealth and Human S · Igf::ot::igf Bioxp Repair Agreement$5K
Show 2 earlier federal awards
- Federal contractCommerce · 3 Dna Plasmid Tests$6K
- Federal contractDefense · Igf::ot::igf Bioxp 3200 System, Wifi$62K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Federal first
96months
from Telesis Bio Inc.’s first federal award to its first private round.
- First federal award · Jun 2015
- Defense · $62K
- First Form D · Jun 2023
- $28M · 1st Form D
- Awards before first raise
- 8 awards
An association in public records, not a cause or a prediction.
Standing among 32 peers
Line = medianBiotech · Device
- Granted patents#11 · top 34%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Andrea L. JacksonDirectorNamed in SEC Form D filings
- Annette V. TumoloDirectorNamed in SEC Form D filings
- Christine A. TsingosDirectorNamed in SEC Form D filings
- Daniel G. GibsonExecutive OfficerNamed in SEC Form D filings
- Eric H. EsserExecutive OfficerNamed in SEC Form D filings
- Franklin R. WitneyDirectorNamed in SEC Form D filings
Show all 11 people
- Jami A. NachtsheimDirectorNamed in SEC Form D filings
- Paul V. MeisterDirectorNamed in SEC Form D filings
- Robert H. CutlerExecutive OfficerNamed in SEC Form D filings
- Todd R. NelsonExecutive Officer, DirectorNamed in SEC Form D filings
- William F. SniderDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 11- PendingMethods of Synthesizing Nucleic Acid MoleculesUSPTOApplication 19121294
- GrantedDigital To Biological ConverterUSPTOUS 12,589,396
- PendingMethods of Synthesizing Nucleic Acid MoleculesUSPTOApplication 18660082
Show all 11 patent records
- Methods of Synthesizing Nucleic Acid MoleculesMay 14, 2026 · Application 19121294Pending
- Digital To Biological ConverterMar 31, 2026 · US 12,589,396Granted
- Methods of Synthesizing Nucleic Acid MoleculesNov 13, 2025 · Application 18660082Pending
- Demand Synthesis of Polynucleotide SequencesNov 7, 2024 · Application 18768490Pending
- Methods for Assembling Nucleic AcidsAug 29, 2024 · Application 18652095Pending
- Apparatus For Delivery Of Laboratory ConsumablesOct 26, 2023 · Application 18138633Pending
- Methods Of Synthesizing Nucleic Acid MoleculesApplication PCTUS2021059422Pending
- Methods of Synthesizing Nucleic Acid MoleculesApplication 63644953Pending
- Apparatus For Delivery Of Laboratory ConsumablesApplication PCTUS2023019668Pending
- Methods Of Synthesizing Nucleic Acid MoleculesApplication PCTUS2022048407Pending
- Methods Of Synthesizing Nucleic Acid MoleculesApplication PCTUS2025028716Pending
Related companies, and why
- Longevity Biotech, IncSimilar federal contract value in Biotech · $348K in contracts
- GENOMIC EXPRESSION INCSimilar federal contract value in Biotech · $340K in contracts
- AFASCI, INC.Similar federal contract value in Biotech · $339K in contracts
- QUALITY BIOLOGICAL, INC.Similar federal contract value in Biotech · $336K in contracts
- NAPO PHARMACEUTICALS INCSimilar federal contract value in Biotech · $335K in contracts
- Ovation.io, Inc.Similar federal contract value in Biotech · $329K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .